z-logo
open-access-imgOpen Access
Low-dose human menopausal gonadotrophin versus clomiphene citrate in subfertile couples treated with intrauterine insemination: a randomized controlled trial
Author(s) -
Karen Peeraer,
Sophie Debrock,
Peter De Loecker,
Carla Tomassetti,
Annouschka Laenen,
Myriam Welkenhuysen,
Luc Meeuwis,
Sofie Pelckmans,
Ben W. Mol,
Carl Spiessens,
Diane De Neubourg,
Thomas D’Hooghe
Publication year - 2015
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/dev062
Subject(s) - menotropins , intrauterine insemination , medicine , gynecology , insemination , clomifene , pregnancy rate , randomized controlled trial , infertility , pregnancy , artificial insemination , andrology , ovulation induction , obstetrics , ovulation , endocrinology , biology , sperm , hormone , genetics
Can controlled ovarian stimulation with low-dose human menopausal gonadotrophin (hMG) improve the clinical pregnancy rate when compared with ovarian stimulation with clomiphene citrate (CC) in an intrauterine insemination (IUI) programme for subfertile couples?

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom